| Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer DC West, M Kocherginsky, EY Tonsing-Carter, DN Dolcen, DJ Hosfield, ... Clinical Cancer Research 24 (14), 3433-3446, 2018 | 66 | 2018 |
| Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth J Kach, TM Long, P Selman, EY Tonsing-Carter, MA Bacalao, RR Lastra, ... Molecular cancer therapeutics 16 (8), 1680-1692, 2017 | 61 | 2017 |
| Self‐assembling peptide gels for 3D prostate cancer spheroid culture KM Hainline, F Gu, JF Handley, YF Tian, Y Wu, L de Wet, ... Macromolecular bioscience 19 (1), 1800249, 2019 | 58 | 2019 |
| SOX2 mediates metabolic reprogramming of prostate cancer cells L de Wet, A Williams, M Gillard, S Kregel, S Lamperis, LC Gutgesell, ... Oncogene 41 (8), 1190-1202, 2022 | 27 | 2022 |
| SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis A Williams, L Gutgesell, L de Wet, P Selman, A Dey, M Avineni, I Kapoor, ... Cancer Letters 565, 216209, 2023 | 2 | 2023 |
| Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells L de Wet, A Williams, M Gillard, S Kregel, S Lamperis, LC Gutgesell, ... Oncogene 41 (8), 1234, 2022 | 1 | 2022 |
| SOX2 mediates metabolic reprogramming of prostate cancer cells (vol 41, pg 1190, 2022) L de Wet, A Williams, M Gillard, S Kregel, S Lamperis, LC Gutgesell, ... ONCOGENE 41 (8), 1234-1234, 2022 | | 2022 |
| The Role of SOX2 in Regulating Metabolism and Enzalutamide Resistance in Prostate Cancer L de Wet The University of Chicago, 2020 | | 2020 |
| SOX2 regulation of FOXP1 as a mechanism driving disparate aggressiveness of prostate cancer in African-American men A Williams, L de Wet, M Gillard, S Kregel, T Garcia, R Szmulewitz, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 147-148, 2018 | | 2018 |
